Eledon Pharmaceuticals to Participate in Two Upcoming Investor Conferences

Rhea-AI Summary

Eledon Pharmaceuticals, listed on NASDAQ as ELDN, announced its participation in two investor conferences. The first event is a fireside chat at the Gilmartin Group Emerging Growth Company Showcase on August 31, 2022, at 2:00 p.m. ET. The second event is a presentation at the H.C. Wainwright 24th Annual Global Investment Conference, available on-demand from September 12, 2022, at 7:00 a.m. ET. Webcast replays will be accessible on the company's website. Eledon focuses on developing treatments targeting the CD40 Ligand pathway, with its lead candidate being tegoprubart.

IRVINE, Calif., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that senior management will participate in two upcoming investor conferences:

• A fireside chat at the virtual Gilmartin Group Emerging Growth Company Showcase on Wednesday, August 31, 2022 at 2:00 p.m. ET; and
  
  
• A company presentation at the H.C. Wainwright 24th Annual Global Investment Conference. The presentation will be available on-demand beginning on Monday, September 12, 2022 at 7:00 a.m. ET.
  

Webcast replays will be accessible on the Events page of the Investors section on the Company’s website at https://ir.eledon.com/events-and-presentations/events.

About Eledon Pharmaceuticals and tegoprubart (formerly AT-1501)

Eledon Pharmaceuticals is a clinical stage biotechnology company using its expertise in targeting the CD40 Ligand (CD40L, also called CD154) pathway to develop potential treatments for persons requiring an organ or cell-based transplant, living with autoimmune disease, or living with ALS. The company’s lead compound in development is tegoprubart, an anti-CD40L antibody with high affinity for CD40 Ligand, a well-validated biological target with broad therapeutic potential. Eledon is headquartered in Irvine, Calif. For more information, please visit the company’s website at www.eledon.com.

Follow Eledon Pharmaceuticals on social media: LinkedIn; Twitter

Investor Contact:

Stephen Jasper
Gilmartin Group
(858) 525-2047
stephen@gilmartinir.com 

 

 

FAQ

When is Eledon's fireside chat at the Gilmartin Group Emerging Growth Company Showcase?

Eledon's fireside chat is scheduled for August 31, 2022, at 2:00 p.m. ET.

What is the date for the H.C. Wainwright 24th Annual Global Investment Conference presentation?

The presentation will be available on-demand starting September 12, 2022, at 7:00 a.m. ET.

Where can I access the webcast replays for Eledon's investor presentations?

Webcast replays can be accessed on the Events page of Eledon's Investors section on their website.

What is Eledon Pharmaceuticals focusing on in its development?

Eledon Pharmaceuticals is developing treatments targeting the CD40 Ligand pathway, with tegoprubart as its lead candidate.

What is the stock symbol for Eledon Pharmaceuticals?

Eledon's stock symbol is ELDN, and it is listed on NASDAQ.